Related Experiment Videos
Adverse reactions to Bactrim--a retrospective view
1F. Hoffmann-La Roche and Co. Ltd., Basle, Switzerland.
Infection
|January 1, 1987
Summary
Evaluating adverse reactions to cotrimoxazole is complex due to inconsistent international assessments and incomplete spontaneous reports. This review highlights challenges in assessing long-established drugs like cotrimoxazole.
Area of Science:
- Pharmacovigilance
- Drug safety evaluation
- Medical history
Background:
- Cotrimoxazole is a widely prescribed antibiotic.
- Adverse reactions to medications require careful monitoring and assessment.
- Historical data on drug safety can be inconsistent.
Purpose of the Study:
- To review the literature on adverse reactions to cotrimoxazole.
- To discuss the challenges in evaluating drug safety for established medications.
- To highlight the impact of data quality on safety assessments.
Main Methods:
- Historical literature survey.
- Analysis of reported adverse events.
- Review of international drug safety assessments.
Main Results:
- Assessments of cotrimoxazole adverse reactions have varied significantly over time and across countries.
- Spontaneous adverse event reports are often incomplete and difficult to verify.
- Evaluating long-established drugs presents unique challenges due to evolving data and reporting standards.
Conclusions:
- A balanced evaluation of cotrimoxazole's safety profile is hindered by inconsistent historical data.
- The reliability of spontaneous reports is a significant limitation in drug safety surveillance.
- Further discussion is needed to establish a clear understanding of cotrimoxazole's adverse reaction significance.